The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.
Neuropharmacology
; 162: 107814, 2020 01 01.
Article
in En
| MEDLINE
| ID: mdl-31628934
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Reward
/
Succinimides
/
Behavior, Animal
/
Carbamates
/
Arachidonic Acids
/
Cues
/
Receptor, Cannabinoid, CB1
/
Endocannabinoids
/
Glycerides
/
Monoacylglycerol Lipases
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
Language:
En
Journal:
Neuropharmacology
Year:
2020
Document type:
Article
Country of publication:
United kingdom